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Abstract: A class of amphiphilic photosensitizers for photodynamic therapy (PDT) was developed.
Sulfonate esters of modified porphyrins bearing—F substituents in the ortho positions of the phenyl
rings have adequate properties for PDT, including absorption in the red, increased cellular uptake,
favorable intracellular localization, low cytotoxicity, and high phototoxicity against A549 (human
lung adenocarcinoma) and CT26 (murine colon carcinoma) cells. Moreover, the role of type I and type
II photochemical processes was assessed by fluorescent probes specific for various reactive oxygen
species (ROS). The photodynamic effect is improved not only by enhanced cellular uptake but also
by the high generation of both singlet oxygen and oxygen-centered radicals. All of the presented
results support the idea that the rational design of photosensitizers for PDT can be further improved
by better understanding the determinants affecting its therapeutic efficiency and explain how smart
structural modifications can make them suitable photosensitizers for application in PDT.
Keywords: anticancer activity; photodynamic therapy; porphyrins; photosensitizers; reactive oxygen
species; singlet oxygen
1. Introduction
Photodynamic therapy (PDT) employs a photoactive molecule named a photosensitizer (PS),
light absorbed by the PS and the molecular oxygen present in tissues to generate reactive oxygen
species (ROS) [1]. ROS, such as singlet oxygen, superoxide ion, or hydroxyl radical, lead to the
oxidation of biologically relevant molecules and cause irreversible destruction of target tissues
by cell death, vascular damage, and inflammation. Compared to traditional treatments (surgery,
radiotherapy, and chemotherapy), PDT is an effective and safe method of cancer treatment with
minimal impact on surrounding healthy tissue. Moreover, PDT leads to the stimulation of
antitumor immune response, which may allow eliminating not only primary tumors but also
protecting against metastases [2–4]. A major challenge in PDT is to develop PS molecules that
absorb light in the phototherapeutic window—the 630–850 nm range—where human tissues are
the most transparent. Porphyrin derivatives [5], including chlorins [6–8] and bacteriochlorins [6],
as well as phthalocyanines [9–11], are the most frequently studied PDT photosensitizers due to their
long-wavelength absorption and their photophysical properties (high yields of long-lived triplet
states) [12–15]. The lowest-electronically excited triplet state of photosensitizer is the precursor of
ROS-generating reactions. ROS may be generated by transferring an electron or hydrogen atom
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(type I processes) or electronic energy (type II processes) to molecular oxygen, with the formation of
oxygen-centered radicals (superoxide ion and hydroxyl radicals) and singlet oxygen, respectively.
Various tetrapyrrolic-based photosensitizers have been approved by the U.S. Food and Drug
Administration (FDA) and have entered clinical practice such as porfimer sodium (Photofrin®),
verteporfin (Visudyne®), temoporfin (Foscan®), and more recently padeliporfin (Tookad Soluble®).
Nevertheless, there are still significant challenges in the development of photosensitizers that have
specificity to tumors cells and adequate clearance from healthy cells. Increased lipophilicity usually
imparts better cellular uptake but may lead to aggregation and decreased ROS generation. Too much
hydrophilicity diminishes active transport across the cell membrane, [16] and limits the use of the
PS to vascular-targeted PDT. Balancing the lipophilic/hydrophilic character of PS is the yin and yang
of cellular uptake and PDT efficacy [4,17]. Various nanoscale drug carriers, such as polymer-based
nanoparticles [18,19], liposomes [20], and polymeric micelles [21,22], have been explored as delivery
systems for both hydrophilic and hydrophobic photosensitizers [23–26]. The polarity and geometry of
substituents around the macrocycle offer decisive control over the amphiphilic character of the PS with
a significant impact on cellular uptake and subcellular localization [27]. Amphiphilic photosensitizers
may be designed to combine increased tumor uptake and rapid systemic clearance [28].
We showed that halogenated and sulfonated porphyrins are simple to synthesize, have
photophysical properties appropriate for PDT, and lead to a photodynamic effect comparable to
that of Photofrin [29]. Subsequently, it was demonstrated that bacteriochlorins (e.g. sulfonamide
derivatives bearing Cl or F substituents in the ortho positions of the phenyl rings) have even better
properties for PDT, including strong absorption in the near-infrared (λmax ≈ 750 nm, ε ≈ 105 M−1cm−1),
excellent cellular uptake, intracellular localization, low cytotoxicity in the dark, and high phototoxicity
upon irradiation with red light [6,28,30–33]. These and other bacteriochlorin-based photosensitizers
proved to be very efficient in vascular-targeted PDT [34,35]. One of these photosensitizers, named
redaporfin, is currently in clinical trials [36]. Following a different strategy, we reported a simple and
efficient synthetic method to tune the amphiphilicity of sulfonate ester porphyrins by selecting the
type and number of fluorine atoms as well as the length of the alkyl sulfonate ester chains [37,38]. It is
recognized that sulfonic acid esters are relatively unstable since they may react with nucleophiles in vitro
and in vivo and possibly hydrolyze to sulfonate. Sulfonic acid esters can act as chemotherapeutics due
to their alkylating properties (e.g., busulfan) [39]. However, the stability of sulfonic acid esters greatly
depends on the substitution pattern. Very stable esters can be obtained if suitable, electron-withdrawing,
deactivating substituents are introduced [40,41].
Sulfonate ester porphyrins bearing fluorine atoms are an interesting template to explore
photosensitizers with polarities that may change after administration in a controlled manner. In the past,
we explored halogenated and sulfonated porphyrins to assess the potential of this molecular template
before preparing the corresponding bacteriochlorin, namely redaporfin. Herein, we characterize
a series of amphiphilic polyfluorinated sulfonate ester porphyrins with four different substitution
patterns in terms of their photochemistry, cellular uptake, subcellular localization, dark cytotoxicity,
and photodynamic effect. We show that sulfonate ester porphyrin derivatives offer new leads for PDT
photosensitizers with appropriate amphiphilicity and high phototoxicity. The chemical structures of
investigated porphyrins are presented in Scheme 1.
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Scheme 1. Chemical structures of fluorinated sulfoester porphyrins studied in this work.
2. Results and Discussion
2.1. Photosensitizers and Their Optical Properties
The synthesis of meso(sulfonate ester fluoroaryl)porphyrins has been previously described [38].
In order to synthesize the desired fluorinated amphiphilic porphyrins, containing sulfonate
ester appendices, the derivatization of 5,10,15,20-tetrakis(2-fluorophenyl)porphyrin and
5,10,15,20-tetrakis(2,6-difluorophenyl)porphyrin into the corresponding chlorosulfonated porphyrins
was achieved by mixing the porphyrins with an excess of chlorosulfonic acid. The chlorosulfonic acid
group is susceptible to react with alcohols in basic conditions. This synthetic strategy allowed us not
only to prepare a family of amphiphilic porphyrins, containing several sulfonate ester appendices, but
also the inclusion of one or more fluorine atoms in the porphyrin structure [38].
Some of us reported the fundamental spectroscopic and photophysical properties of investigated
photosensitizers determined in ethanol [31,38]. The ground state absorption and fluorescence spectra of
sulfonate ester porphyrin derivatives, recorded at room temperature in DMSO, are presented in Figure 1.
The spectra of all porphyrins show the characteristic bands originated from free base porphyrin with
the D2h symmetry. While symmetry dictates the presence of distinct Bx and By transitions, a single Soret
band is observed at ~420 nm in the experimental spectrum, which is typical for free-base porphyrins.
An interesting feature that is a fingerprint of free-base porphyrins is the presence of four Q bands in the
visible region. These extra bands are due to vibrational coupling effects, namely vibronic structures,
and derive from the break of the degeneration of the LUMOs b2g and b3g introduced by the presence
of NH central bonds [42,43].
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Figure 1. UV-VIS-NIR electronic absorption and fluorescence (dashed) spectra of investigated
porphyrins: (a) F2PC3H4F3, (b) FPC4H3F6, (c) FPC3H7, (d) F2PC4H3F6 registered in DMSO at
room temperature.
Their spectra can be interpreted in terms of the four orbital Gouterman’s model, where the
principal excitations involve the two highest occupied molecular orbitals (HOMO and HOMO-1) and
the two lowest unoccupied molecular orbitals (LUMO and LUMO+1). S1 and S2 are mixing both H→L
and H→L+1 orbitals and may even include other small contributions, which was confirmed by our
results. The calculations of theoretical spectra presented in Table S1 and Table S2 are in line with this
assignment. The comparison with experimental UV-Vis-NIR electronic absorption spectra registered in
DMSO reveals that the theoretical energies of the transitions are ca. 0.1 eV higher than the experimental
values, and up to 0.3 eV higher for the transition of the lowest energy. The isodensity contour plots are
centered on the porphyrin ring without a significant contribution from the fluorinated substituents
and confirmed that they all have a π−›π* character (Figure S1).
The longest-wavelength absorption band at 635–645 nm is crucial for PDT application, because
only red and NIR light has sufficient tissue penetration ability. The fluorescence excitation spectra of
all the compounds are typical and correspond well with their absorption spectra. Similar spectroscopic
properties characterize all of the studied porphyrins. However, according to our previous data published
for sulfonic derivative (F2POH), some of them (especially difluorinated ones) are characterized by a more
intense Qx band, which is further displaced to the red region of spectra (close to 650 nm). Considering
that F2POH was shown to be efficient photosensitizer in vitro in both anticancer photodynamic effect
as well as antimicrobial photoinactivation [31], it can be expected that the sulfonate ester substituents
studied in this work may increase the phototoxicity of these photosensitizers.
2.2. Detection of Reactive Oxygen Species Using Fluorescent Probes
Considering the potential applications of investigated porphyrins, their ability to generate ROS
via type I (hydrogen or electron transfer) or type II (energy transfer) photochemical reactions were
determined using fluorescent probes selective or specific for each species (APF, HPF, SOSG), Figure 2.
As indicated, even though 1O2 (1∆g) is thought to be the dominant cytotoxic ROS in porphyrin-mediated
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PDT, other types of ROS can also be generated through photoinduced electron transfer reaction.
The Φ∆ values are strongly affected by the substitution pattern and reached the highest values for
polyfluorinated sulfonate ester 0.81 ± 0.02 for FPC4H3F6, 1.0 ± 0.04 for F2PC4F3F6 and relatively
lower for porphyrins with reduced fluorine atoms in alkoxy chain F2PC3H4F3 and FPC3H7 (0.74) [38].
The significantly higher Φ∆ values can be related to the presence of many electron-withdrawing groups
and heavy atom effect in the PS structure leading to higher 1O2 generation, reflecting an optimized
triplet energy transfer from these compounds to molecular oxygen.
Figure 2. Detection of photogenerated reactive oxygen species using fluorescent probes at a
concentration of 15 µM: APF (a,b), HPF (c,d), SOSG (e,f); during irradiation of photosensitizer
solution (10 µM).
The singlet oxygen quantum yield determined for fluorinated porphyrin with the highest number
of halogenated atoms in alkoxy chain (Φ∆ = 1.0 ± 0.04 for F2PC4H3F6) is significantly higher than
those observed for the porphyrin with nonfluorinated sulfoester substituents (Φ∆ = 0.74 ± 0.02 for
FPC3H7, respectively) [38]. These results are in agreement with those obtained with SOSG, which also
indicated that polyfluorinated sulfonate ester derivative is a relatively better singlet oxygen generator
(Figure 2). This effect can be related to the nature of each substituent, because halogen atoms enhance
the heavy atom effect due to spin-orbital coupling, and consequently, promote the singlet oxygen
quantum yields [44,45]. On the other hand, the competitive type I mechanism may occur and also play
an important role in PDT. To confirm the presence of type I reaction products, we applied APF and
HPF probes. HPF was reported as selective and specific for •OH, whereas APF can also be sensitive
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to other radical species [46]. As shown in Figure 2, the increase in fluorescence signal derived from
each probe can be observed with increased light dose. Hence, both type I and type II mechanisms
may occur competitively, and their relative contributions depend on the photosensitizer, substrates,
and environment [47].
It should be noted that we used two light sources for selected porphyrin due to their differences
in the absorption maximum in the phototherapeutic window. The application of the 635 nm emitting
diode and 655 nm diode laser light allow us to excite the compounds with appropriate wavelengths
and then determined applied light doses. Therefore, a more direct comparison between all the
photosensitizers was possible. The same light source and experimental conditions were employed for
each photosensitizer in in vitro photodynamic activity evaluation.
2.3. Lipophilicity of Photosensitizer (logP Determination)
Lipophilicity of photosensitizers was estimated by the logarithm of a partition coefficient, logP,
which reflects the equilibrium partitioning of a molecule between a nonpolar and a polar phase,
such as an n-octanol/PBS system. Partition coefficients were obtained experimentally by the modified
shake-flask method and are presented in Table 1 in terms of their logarithmic values (logP). These results
confirm the hydrophilicity of sulfonate derivative (F2POH), whereas the data obtained from a set of
sulfonate ester porphyrin revealed the increased, but similar lipophilicity (logP 1.4–1.6). The results
indicate that besides the overall amphiphilicity, the presence of sulfonate ester in a molecule effectively
increases logP value as compared with hydrophilic, sulfonic analog F2POH (logP = –1.7). This effect
plays an important role in their cellular uptake by cancer cells, tumor selectivity, and overall PDT
efficacy [30,48,49].










The time-dependent accumulation of sulfonate ester porphyrins and their sulfonic analog in A549
and CT26 cells exposed to 5 µM photosensitizer concentration is shown in Figure 3. The data indicate
enhanced cellular uptake in both cell lines for sulfonate ester derivatives. In A549 cells, the uptake
stabilizes after 12 h of incubation, while the accumulation in CT26 continues to increase for a longer
time. After 24 h of incubation the following orders of increasing accumulation were found: FPC4H3F6
> F2PC4H3F6 ≈ F2PC3H4F3 ≈ FPC3H7 >> F2POH for A549 cells and FPC4H3F6 > FPC3H7 > F2PC3H4F3
> F2PC4H3F6 >> F2POH for CT26. We also confirmed those trends in CT26 cells by performing flow
cytometry analysis that also indicated the most effective cellular uptake for FPC4H3F6, Figure 4.
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Figure 3. Time-dependent cellular uptake of investigated porphyrins at 20 µM by (a) A549 and (b)
CT26 cells determined by fluorescence intensity measurements in cellular extracts of each compound.
Figure 4. Cellular uptake determined in CT26 cells based on the red fluorescence of each porphyrin
using flow cytometry. Histograms of the fluorescence intensities of the photosensitizer in CT26 (colored)
or untreated cells (gray): (a) F2POH, (b) F2PC4H3F6, (c) FPC3H7, (d) F2PC3H4F3, (e) FPC4H3F6.
The cells (0.5×106 cells/mL) were incubated with 20 µM PS for 24 h, then washed twice with HBSS and
analyzed with flow cytometry.
In all cases, the highest uptake was observed for the sulfonate ester photosensitizers and the
lowest for the sulfonated one. The replacement of the sulfonic groups, which are ionized in PBS, by the
sulfonate ester groups appreciably enhances cellular uptake. Under these conditions, the chromophore
of sulfonate ester porphyrins seems to be stable. Their higher cell uptake is consistent with the higher cell
membrane permeation of neutral and amphiphilic drugs. They seem to combine enough lipophilicity
to increase the affinity toward cells but not as much as to aggregate extensively in an aqueous culture
medium. Based on the singlet oxygen quantum yields and the amount of photosensitizer present in
the cells, it can be expected that sulfonate ester derivatives are interesting photosensitizers for PDT.
2.4.2. CLSM Imaging and Subcellular Localization
The intracellular localization of a photosensitizer is important to determine its initial targets
in PDT [50]. We employed confocal laser scanning microscopy (CLSM) to analyze the subcellular
accumulation of studied photosensitizers using their intrinsic fluorescence and that of organelle-specific
probes. The CT26 cells were cultured for 24 h with FPC4H3F6, taken as representative of sulfonate ester
porphyrins, and separately with the hydrophilic derivative (F2POH), at 20 µM concentration. For CLSM
imaging, each porphyrin was subsequentially incubated with a specific probe for mitochondria
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(MitoTracker), endoplasmic reticulum (ERTracker), or lysosomes (LysoTracker). The overlaid images
are shown in Figure 5, in which the fluorescence of the porphyrin is shown in red, the fluorescence of
the organelle-specific probe is shown in green, and blue fluorescence from Hoechst33342 was used to
visualize nuclei. The intensity of FPC4H3F6 fluorescence is higher than that of F2POH as expected
from its higher internalization in the cells. Due to the inconsistency in the labeling pattern on the
panels presented for different organelle-probe related to the different imaging planes, the wider field
of view for F2POH and FPC4H3F6 with more cells in each panel, registered with the same imaging
plane is showed in Figure S2. The intracellular fluorescence from FPC4H3F6 presents several distinct
red emission pixels and some overlap with both the LysoTracker and the ERTracker, suggesting that
structural modification at the sulfonate ester moiety may have taken place after uptake. Interestingly,
the fluorescence of F2POH also overlaps with these two probes. Sulfonate ester porphyrins likely
hydrolyze in the acidic lysosomal environment, and more than one species is present after 24 h of
incubation of FPC4H3F6 with the cells. The images registered for the other three photosensitizers
are presented in Figures S3–S5. It should be highlighted that these PSs distribute very broadly in
various intracellular compartments. A similar effect was also observed for other ester-substituted
photosensitizers, e.g., pyropheophorbide a methyl ester—which was reported to be localized in the
endoplasmic reticulum, Golgi apparatus, lysosomes, and mitochondria in NCI-h446 cells [51].
Figure 5. Cont.
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Figure 5. Laser scanning confocal fluorescence microscopy images of cells showing intracellular
localization of F2POH and FPC4H3F6. Cells were marked with specific probes for endoplasmic
reticulum (ERTracker), lysosomes (LysoTracker), and mitochondria (MitoTracker).
Based on these data, it can be concluded that the substitution of porphyrin by fluorosulfonate
ester increases its uptake by lysosomes and mitochondria, and consequently decreases the localization
in the nuclei. To support these data, we include the topographic fluorescence profiles recorded after
cells were co-stained with FPC3H7 or FPC4H3F6 and organelle-specific fluorescent probes as well
as Pearson’s correlation coefficients (R), Figure S6. The different localizations of FPC4H3F6 and its
hydrolysis products may trigger a greater diversity of mechanisms of cell death [52].
2.4.3. Cytotoxicity in the Dark
To evaluate the potential application of sulfonate ester porphyrins as efficient photodynamic
therapeutic agents, their dark and phototoxicity towards A549 and CT26 cells were investigated using
MTT assay (Figure 6). The toxicity in the dark of investigated photosensitizers was tested after 24 h of
incubation (maximal uptake determined experimentally). Exposure to the cells to concentrations below
50 µM did not reveal significant cytotoxicity. FPC3H7 at 50 µM showed the highest toxicity towards
A549 cells, with ca. 20% mortality. F2PC3H4F3 reduced of CT26 cells viability by ca. 40% at the same
concentration. Similar results were also obtained for sulfonamide analogs [30,31]. For comparison,
sulfonate porphyrins showed cytotoxicity at 100 µM concentrations [29]. The lower dark cytotoxicity
of hydrophilic porphyrins may be related to their lower uptake. In view of these low cytotoxicities, we
employed a concentration of 20 µM to investigate the in vitro efficacy of sulfonate ester photosensitizers.
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Figure 6. Cytotoxicity of sulfonate ester porphyrins tested in the dark against (a) A549 and (b) CT26
cancer cells.
2.4.4. ROS Generation In Vitro
The ability of the investigated porphyrin to ROS formation in vitro was assessed by the flow
cytometry. For this purpose, the APF probe (25 µM) was incubated for 2 h following 24 h incubation of
CT26 cells with each porphyrin (20 µM). Moreover, due to the fact that singlet oxygen sensor green
(SOSG) does not enter living cells, we resorted to use the APF, which also is fluorescent in the green;
thus, APF may be used for studying the red fluorophores in the two-color analysis. In contrast to SOSG,
the APF is only partially sensitive singlet oxygen but mainly responds to other reactive oxygen species,
in particular hydroxyl radicals. Therefore, we ascribed the fluorescence signal to ROS generated by
photosensitizers. The results presented in Figure 7 demonstrate that significant green fluorescence
appears in the cells upon irradiation with the red light.
Figure 7. Flow cytometry analysis of reactive oxygen species (ROS) generation in vitro. After incubation
of the cells with PS (24 h) and APF (2 h), the cells were irradiated. The level of ROS was monitored by
the APF fluorescence signal in the green channel and the cellular uptake (red porphyrin fluorescence)
was detected as an increased red fluorescence signal.
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Using the total cellular fluorescence as a measure of the amount of ROS formed, the flow cytometry
data show that under similar conditions, ROS production is effective for all the photosensitizers
accumulated in the cells. These data also demonstrated that the fluorescence intensity of the APF probe
in the cells incubated with porphyrin and exposed to 10 J/cm2 red light was significantly higher than
that of non-stained control cells (PS-/APF-) as well as cells stained only with APF (PS-/APF+), which
indicated the detectable signal. The APF-positive population in this sample may be related to the
presence of a naturally-occurring intracellular ROS level or APF autofluorescence. The augmentation
of the ROS production in cells with accumulated photosensitizers (red fluorescence signal) was nearly
three-fold higher than in cells without photosensitizer. Thus, it suggests that the cellular uptake
of porphyrins correlates with their enhanced ROS generation in vitro and, consequently, the overall
photodynamic activity. Moreover, our results indicated that the level of oxidative stress was always
higher in cells treated with fluorinated sulfonate ester porphyrins than treated with a sulfonated one
(F2POH). These studies are also consistent with the data in Figure 3 (cellular uptake) and strengthen
the view that the fluorinated sulfoester substituents may increase the phototoxicity of photosensitizers,
which correlates best with the efficiency of generation of oxygen-centered radicals.
2.4.5. Photodynamic Effect
Cells incubated with photosensitizers were irradiated with various red-light doses. Irradiation of
the A549 and CT26 was performed following 24 h cells incubation with 20 µM porphyrins that allow
efficient intracellular accumulation (vide uptake studies). The survival fraction after the photodynamic
effect is presented in Figure 8.
Figure 8. Survival fraction of A549 (a,b) and CT26 (c,d) cells in the presence of sulfonate ester
porphyrins as a function of applied red-light doses. The data shown are the means ± SEM of three
independent experiments.
The results indicate that both difluoro-substituted porphyrins are more effective in photodynamic
killing than monofluorinated derivatives. We found that F2PC3H4F3 is particularly phototoxic.
Interestingly, this is not the photosensitizer with the highest cellular uptake. However, it is this PS
that gives the higher signal with APF and HPF, suggesting that type I reactions may be important
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for the phototoxicity of this photosensitizer. Moreover, it can be highlighted that sulfonate esters
photosensitizers are more phototoxic than the sulfonated one, as expected from the higher intracellular
accumulation. To better illustrate the phototoxicity of a group of photosensitizers, we also examined
the morphological changes in cells after photodynamic treatment using optical microscopy, see
Figure 9. Presented images reveled that all PDT treated cells were partially or completely dead 24 h
after treatment.
Figure 9. The morphology of A549 and CT26 cells before and 24 h after photodynamic effect with
sulfonate ester porphyrins at the drug dose of 20 µM and light dose of 5 J/cm2.
3. Materials and Methods
3.1. Chemicals
The 5,10,15,20-tetrakis(2,6-difluoro-3-chlorosulfophenyl) porphyrin alkoxy derivatives were
prepared according to reported procedures [6]. All employed solvents were purchased from
Sigma-Aldrich (Saint Louis, MO, USA) and used without further purification.
3.2. UV/VIS/NIR Electronic Absorption and Emission Spectra Measurements
Solutions containing samples of photosensitizers were dissolved in DMSO. UV/VIS/NIR electronic
absorption spectra were recorded in quartz cuvettes (l = 1 cm) using Shimadzu 2100 spectrophotometer
(Shimadzu Corp., Kioto, Japan). Fluorescence emission spectra were recorded from 550 nm to 750 nm
with excitation at the Soret band (420 nm) using a Fluorescence Spectrometer LS 55 (Perkin Elmer,
Cracow, Poland) [31].
3.3. Detection of Reactive Oxygen Species
The 3′-p-(aminophenyl)fluorescein (APF), 3′-p-(hydroxyphenyl)fluorescein (HPF), and Singlet
Oxygen Sensor Green® (SOSG) were employed as a molecular probe for detection of reactive
oxygen species formation during irradiation. Sulfonate ester porphyrin solutions were diluted to
a concentration of 5 µM per well in PBS (final DMSO concentration did not exceed 0.5%). Next,
the fluorescent probes were added to each well at a final concentration of 10 µM. Photosensitizer
solutions were irradiated with the 635 nm or 655 nm laser diode, and the light was delivered for various
time intervals. The microplate reader (Tecan Infinite M200 Reader; Tecan, Männedorf, Switzerland)
was used for the acquisition of fluorescence signals immediately before and after irradiation [31].
When APF/HPF was employed, fluorescence emission at 515 nm was measured upon excitation at
490 nm. With SOSG, the corresponding values were 525 and 505 nm, respectively.
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3.4. n-Octanol/Water Partition Coefficients
The n-octanol/PBS partition coefficients were determined following the shake-flask method with
minor modification. The porphyrin was dissolved in n-octanol previously saturated with a solution of
PBS. The same volume of PBS saturated with n-octanol was added and mixed on a vortex, and then,
the phases were separated by centrifugation. Next, the PBS/n-octanol phase was taken and diluted to
obtain 0.5% of PBS/n-octanol content in the final solution. This solution was left into the ultrasonic
bath. The fluorescence of each solution was measured using Fluorescence Spectrometer LS 55 (Perkin
Elmer, Cracow, Poland) and compared with the calibration curve to obtain the concentration of the
photosensitizer. The partition coefficient was calculated from the ratio coct/cPBS, where coct and cPBS
are the concentrations of the porphyrin derivatives in the n-octanol and the PBS [31].
3.5. Cells Culture
Human lung adenocarcinoma (A549) and murine colon carcinoma (CT26) cells were grown in
a Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 10% fetal bovine serum (FBS)
and antibiotics (PAN-Biotech GmbH, Aidenbach, Germany). The cells were cultured in incubators
maintained at 37 ◦C in a 95% atmospheric air and 5% CO2 humidified atmosphere. All experiments
were performed on cells in the logarithmic phase of growth. Media were replaced every two days,
and cells were subcultured using 0.25% trypsin-EDTA.
3.6. Cellular Uptake
Cells were seeded on 96-plate microplate (104 per well). After 24 h, the cells were incubated
with each porphyrin-based photosensitizer for various time intervals from 2 h up to 24 h. The
appropriate controls were included. The solutions of photosensitizers were prepared by diluting
the porphyrin stock solution in DMSO with the culture medium to the desired final concentration
(20 µM). The highest concentration of DMSO in the medium did not exceed 0.5%. After incubation,
the cells were washed two times with warmed PBS and solubilized in 30 µL of Triton X-100 and
70 µL of DMSO/ethanol solution (1:3). The retention of cell-associated porphyrin was detected by
fluorescence measurement with the microplate reader (Tecan Infinite M200 Reader, Tecan, Männedorf,
Switzerland) [31]. Cellular uptake of investigated photosensitizers was also determined using flow
cytometry and quantified based on porphyrin’ red fluorescence. For this analysis, the CT26 cells
(0.5×106 cells) seeded in the six-well plate were incubated with each porphyrin at 20 µM for 24 h. After
this incubation, cells were washed two times with HBSS and harvested for analysis. Then, cells were
collected by centrifugation and then resuspended in 200 µL of PBS. Stained cells were then examined
using Guava® easyCyte™ flow cytometer equipped with 488 nm laser. Obtained data were analyzed
using InCyte software (MerckMillipore, Burlington, MA, USA).
3.7. Confocal Laser Scanning Microscopy (CLSM) Imaging
The intracellular accumulation of selected porphyrins was assessed in the CT26 cancer cell line.
Before imaging, CT26 cells were seeded on microscopic slides at a density of 1·105 cells and were
kept at 37 ◦C in a 95% atmospheric air and 5% CO2 humidified atmosphere for 24 h. After being
washed with fresh medium, the cells were incubated in the dark with 20 µM solution of each porphyrin
prepared cell medium for 24 h. Next, after being washed with HBSS, the cells were incubated with
specific intracellular organelle probes: 100 nM Mito-Tracker green, 1 µM ERTracker green, 1 µM
LysoTracker green (Molecular Probes, Invitrogen Life Technologies; Thermo Fisher Scientific, Waltham,
Massachusetts, USA), diluted in HBSS buffer. In addition, cells were incubated for 10 min with
Hoechst33342. After 30 min incubation, at 37 ◦C, in the dark, the cells were washed with HBSS two
times, and the slide was transferred to the microscope stage and cells were visualized under a confocal
microscope Zeiss LSM 880 (Carl Zeiss, Jena, Germany) with a 63× oil immersion objective. Images were
analyzed by Zeiss ZEN Software.
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3.8. Dark Cytotoxicity and Cells Viability Assay
To assess the dark cytotoxicity of sulfonate ester porphyrins induced in A549 and CT26 cancer
cells, after cell attachment, porphyrin solutions prepared in culture medium at concentrations from 0
to 500 µM was added to the cell cultures. Treated cell cultures were incubated for ca. 24 h in the dark.
Next, the photosensitizer solutions of each well were removed, cells were washed in PBS, and fresh
culture medium supplemented with PBS and antibiotics was added to each well, and cells were
returned to the incubator for 24 h. Next, the viability of the cells was calculated based on the MTT
(3-(4,5-dimethylthiazol-2-yl)2,5-diphenyl tetrazolium bromide) assay. MTT dissolved in PBS at content
10% of the final solution was added to each well, and the microplates were further incubated for ca. 3 h.
The medium was then discarded, and 100 µL of the mixture of DMSO/methanol (1:1) were added to the
cultures and mixed thoroughly to dissolve the dark blue crystals of formazan. Formazan quantification
was performed using an automatic microplate reader (Tecan Infinite M200 Reader; Tecan, Männedorf,
Switzerland) by absorbance measurements with a 565 nm test wavelength.
3.9. ROS Generation In Vitro
ROS generation in vitro was investigated using dual-color flow cytometry analysis quantified
after 24 h incubation of CT26 cells with each photosensitizer (20 µM). After this incubation, cells
were washed with HBSS and then incubated with APF (25 µM) prepared in HBSS for the next 2 h.
After this time, cells were washed twice with HBSS and irradiated with 10 J/cm2 red light (LED
diode, 635 ± 20 nm, Instytut Fotonowy, Cracow, Poland). After irradiation, cells were collected by
centrifugation, resuspended in 200 µL of HBSS examined using Guava® easyCyte™ flow cytometer
equipped with 488 nm laser. Obtained data were analyzed using InCyte software (Merck Millipore,
Burlington, MA, USA).
3.10. In Vitro Phototoxicity of Sulfonate Ester Porphyrins
The A549 and CT26 cells were seeded into a 96-wells culture plate (104 cells per well) and kept at
37 ◦C in a 95% atmospheric air and 5% CO2 humidified atmosphere for 24h. Cells were incubated
with fluorinated sulfonate ester porphyrins (F2PC3H4F3, FPC4H3F6, FPC3H7, and F2PC3H4F6) at
20 µM for 24 h. The photosensitizer’s solutions were then removed, the cells were washed in PBS
and irradiated with the 635 nm laser diode light (High Power Monochromatic Light System and
LED Illuminator, Instytut Fotonowy, Poland) or 655 nm laser light for various time intervals. In all
experiments, the light dosimetry was performed and controlled using Ophir NOVA II radiometer (Laser
Measurements Group, Ophir Optronics, Jerusalem, Israel). After the irradiation, the PBS was replaced
by the growth medium, and plates were returned to the incubator (37 ◦C, 5% CO2). Twenty-four
hours after irradiation, cells viability was determined by an MTT assay. Data were expressed as mean
fluorescence intensity value and standard error of the mean. The morphology of A549 and CT26 cells
were investigated before and after photodynamic treatment. The cells were observed using optical and
fluorescence microscopy (Olympus BX51 Microscope; Olympus, Tokio, Japan).
4. Conclusions
The design and development of new photosensitizers for PDT remains an appealing research field.
In this work, the properties of sulfonate ester fluorinated porphyrins were examined to investigate
the potential of this molecular template for PDT. Their absorption bands at 630–650 nm do not have
particularly high absorption coefficients, but if this template is useful for PDT, they may, in a later stage,
be reduced to the corresponding chlorins or bacteriochlorins. We showed that their triplet lifetimes are
long enough and lead to ROS quantum yields higher than 0.6. It has been found that the biological
properties of photosensitizers depend greatly on the molecular substitution pattern. Compared to the
hydrophilic analog (F2POH), the sulfonate esters indicate higher lipophilicity as well as more efficient
ROS generation. In vitro studies of cellular uptake and subcellular localization showed important
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differences between studied photosensitizers. It seems that the sulfonate ester fluorinated porphyrins
are efficiently internalized by the cells and then may hydrolyze to some extent. The sulfonate ester
porphyrins were tested against two cancer cell lines of different tissue origin, A549 (human lung
adenocarcinoma) and CT26 (murine colon carcinoma). Cytotoxicity assays indicated that the onset of
cytotoxicity in the dark takes place at ca. 50 µM, which is a rather low cytotoxicity. One of the sulfonate
ester fluorinated porphyrins (F2PC3H4F3) exhibited remarkable phototoxicity. This result is enabled
by the low tendency to aggregate, high efficiency in generating ROS, and improved cellular uptake
comparing to sulfonated porphyrin. However, it should be clearly stated that its highest photodynamic
efficiency among the tested compounds does not correlate best with either PS cellular uptake or singlet
oxygen quantum yield but with the efficacy of this PS to generate oxygen-centered radicals via type I
mechanism. Fluorinated porphyrins with sulfonate ester substituents also bearing fluorine atoms are
promising candidates for new templates of PDT photosensitizers.
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/21/8/2786/
s1.
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29. Dąbrowski, J.M.; Pereira, M.M.; Arnaut, L.G.; Monteiro, C.J.; Peixoto, A.F.; Karocki, A.; Urbańska, K.;
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41. Dąbrowski, J.M.; Pucelik, B.; Regiel-Futyra, A.; Brindell, M.; Mazuryk, O.; Kyzioł, A.; Stochel, G.;
Macyk, W.; Arnaut, L.G. Engineering of relevant photodynamic processes through structural modifications
of metallotetrapyrrolic photosensitizers. Coord. Chem. Rev. 2016, 325, 67–101. [CrossRef]
42. Arnaut, L.G. Design of porphyrin-based photosensitizers for photodynamic therapy. In Advances in Inorganic
Chemistry; Elsevier: Amsterdam, The Netherlands, 2011; Volume 63, pp. 187–233.
43. Dini, D.; Calvete, M.J.; Hanack, M.; Pong, R.G.; Flom, S.R.; Shirk, J.S. Nonlinear transmission of a
tetrabrominated naphthalocyaninato indium chloride. J. Phys. Chem. B 2006, 110, 12230–12239. [CrossRef]
[PubMed]
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